The study aimed to investigate antibody responses in patients with chronic lymphocytic leukemia (CLL) after first and second Covid-19 vaccinations.  

This study concluded that antibody responses of these patients are lower than that of healthy people. 

This study assessed the effectiveness of Fluxonorm® herbal supplement when combined with standard therapy for lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The authors concluded that the effectiveness of standard therapy was improved by the addition of Fluxonorm® in patients with BPH.

This study compared the effectiveness and safety of tofacitinib (Xeljanz) and baricitinib (Olumiant) in patients with rheumatoid arthritis in a real-world setting. The data showed that tofacitinib and baricitinib had similar effectiveness and safety but clinical responses may depend on previous use of anti-rheumatic drugs.

This study investigated the long-term safety and effectiveness of tandem chimeric antigen receptor (tCAR) T-cell therapy for patients with relapsed or refractory (r/r) non-Hodgkin lymphoma (NHL). The data showed that tCAR T-cell therapy resulted in long-term remission rates with manageable side effects for these patients.

This study evaluated the role of ¹⁸F-fluciclovine-PET-CT versus conventional imaging (bone scan and either CT or MRI) alone for salvage radiotherapy (RT) after prostate surgery for the treatment of patients with localized prostate cancer (PCa). The data showed that including ¹⁸F-fluciclovine-PET-CT into the decision-making process for RT after surgery significantly improved survival without recurrence for these patients.

This study evaluated the effectiveness and safety of adding isatuximab (Sarclisa) to carfilzomib (Kyprolis) and dexamethasone (Decadron) combination (Kd) for patients with previously treated relapsed multiple myeloma (MM). The data showed that adding isatuximab to the Kd regimen reduced the risk of disease progression or death for these patients.

This study looked at the association between the number of calories a person eats and the amount of salt consumed in people with high blood pressure. They found that people with increased weight and high blood pressure had a higher level of salt consumption.

This study looked at the risk of urogenital infections in patients with diabetes taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. It found that SGLT2 inhibitors increase the risk of urogenital infections in women over 50 years of age, especially in the first month of treatment.

This study looked at the use of levodopa-carbidopa intestinal gel (LCIG; Duodopa) for the treatment of severe dyskinesia in patients with advanced Parkinson's disease (PD). It found that LCIG improved symptoms in most patients but that dose adjustments were needed throughout treatment.

This study investigated the effectiveness and safety of rupatadine (RUP; Rupafin) and montelukast (MON; Singulair) as additive therapies for patients with rheumatoid arthritis (RA). The authors concluded that RUP and MON provided clinical and functional improvements in these patients.